Drug Profile


Alternative Names: Tikosyn; UK 68; UK 68798; Xelide

Latest Information Update: 31 May 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pfizer
  • Class Class III antiarrhythmics; Phenethylamines; Small molecules; Sulfonamides
  • Mechanism of Action Potassium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Atrial fibrillation; Atrial flutter
  • Discontinued Arrhythmias

Most Recent Events

  • 02 Mar 2004 Discontinued - Preregistration for Arrhythmias in Europe (PO)
  • 02 Mar 2004 Discontinued - Preregistration for Atrial fibrillation in European Union (PO)
  • 02 Mar 2004 Discontinued - Preregistration for Atrial flutter in European Union (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top